Surge In Congenital Heart Disease Fuels The Growth Of The Pediatric Interventional Cardiology Market: A Key Factor Shaping the Future of the Pediatric Interventional Cardiology Market in 2025

How Are the key drivers contributing to the expansion of the pediatric interventional cardiology market?
The pediatric interventional cardiology market is anticipated to grow due to the rising presence of congenital heart disease. This term refers to any issue affecting the heart's structure from birth. The advantage of pediatric interventional cardiology procedures over traditional open-heart surgeries include shorter recovery periods, a lower infection risk, and minimal scarring. As reported by the American Heart Association in 2022, a non-profit organization based in the US that emphasizes cardiovascular medical research, nearly 40,000 US infants are impacted by congenital heart defects annually, and the birth prevalence of such heart diseases is approximately 12.3 per 1000. Additionally, The Lancet, a UK-based general medical weekly peer-reviewed journal, published an article in 2022 indicating that congenital heart disease is the primary birth defect, influencing nearly nine in every 1000 live births. Consequently, the ascending predominance of congenital heart disease will fuel the growth of the pediatric interventional cardiology market.

Get Your Pediatric Interventional Cardiology Market Report Here:
https://www.thebusinessresearchcompany.com/report/pediatric-interventional-cardiology-global-market-report

What growth opportunities are expected to drive the pediatric interventional cardiology market's CAGR through 2034?
In the previous years, there has been significant growth in the market size of pediatric interventional cardiology. It is expected to expand from $2.44 billion in 2024 to $2.62 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. This growth during the historical period can be linked to factors such as heightened awareness of mycotoxins, strict regulatory norms, emphasis on animal health, globalization of poultry production, market competitiveness, and improved farm productivity.

The market size of pediatric interventional cardiology is anticipated to witness robust expansion in the forthcoming years, elevating to "$3.61 billion in 2029, displaying a compound annual growth rate (CAGR) of 8.3%. The escalation during the projected period is linked to the evolving poultry industry, the repercussions of climate change, the surge in demand for organic items, alterations in global commerce, governmental initiatives, and heightened health awareness. Key trends during the forecast period comprise technology integration, enhancements in feed quality and safety, market unification, cooperative research initiatives, acceleration of digitalization in agriculture, and progressions in feed technology.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10384&type=smp

What are the emerging trends shaping the future of the pediatric interventional cardiology market?
In the pediatric interventional cardiology market, product innovation is a predominant trend. Major players are introducing cutting-edge solutions to solidify their market standing. For instance, Medtronic plc., a medical devices company based in the US, unveiled a trans catheter pulmonary valve, known as the Harmony Transcatheter Pulmonary Valve System, in February 2023. The Harmony TPV system is a less invasive substitute for open-heart surgery which can be inserted through a minor incision in the leg or neck. This system is designed for patients who have had prior surgery for congenital heart disease and have a dysfunctional RVOT (right ventricular outflow tract) due to an earlier implanted conduit or bio prosthetic pulmonary valve. It's also recommended for patients with native or patched RVOT who need pulmonary valve replacement.

Which growth-oriented segments of the pediatric interventional cardiology market are leading the industry's development?
The pediatric interventional cardiology market covered in this report is segmented -

1) By Device Type: Closure Devices, Trans catheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Other Device Types
2) By Procedure: Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Other Procedures
3) By End-Use: Clinical Testing Laboratories, Hospitals, Cardiac Centers, Pediatric Clinics, Research Institutions

Subsegments:
1) By Closure Devices: Atrial Septal Defect (ASD) Closure Devices, Ventricular Septal Defect (VSD) Closure Devices, Patent Ductus Arteriosus (PDA) Closure Devices
2) By Transcatheter Heart Valves: Transcatheter Aortic Valve Replacement (TAVR) Devices, Transcatheter Mitral Valve Repair Devices, Transcatheter Pulmonary Valve Replacement Devices
3) By Atherectomy Devices: Directional Atherectomy Devices, Rotational Atherectomy Devices, Laser Atherectomy Devices
4) By Catheters: Diagnostic Catheters, Therapeutic Catheters, Guiding Catheters
5) By Balloons: Balloon Angioplasty Balloons, Intra-Aortic Balloons, High-Pressure Balloons
6) By Stents: Drug-Eluting Stents, Bare-Metal Stents, Bioresorbable Stents
7) By Other Device Types: Vascular Closure Devices, Hemodynamic Monitoring Devices, Electrophysiology Devices

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10384

What regions are leading the charge in the pediatric interventional cardiology market?
North America was the largest region in the pediatric interventional cardiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global pediatric interventional cardiology market during the forecast period. The regions covered in the pediatric interventional cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What companies are at the forefront of innovation in the pediatric interventional cardiology market?
Major companies operating in the pediatric interventional cardiology market include Medtronic plc, GE HealthCare Technologies Inc., Abbott Laboratories, Terumo Corporation, W.L. Gore & Associates Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Siemens Healthineers, Numed Inc., St. Jude Medical Inc., Cordis Corporation, Koninklijke Philips N.V., Biotronik, B. Braun Melsungen AG, Canon Medical Systems Corporation, Gore & Associates Inc., Johnson and Johnson, Cook Group LLC, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Lepu Medical Technology (Beijing) Co.Ltd., Biosensors International Group Ltd., Cardiac Science Corporation, Asahi Intecc Co.Ltd., Medinol Ltd., Jotec GmbH, Hexacath Ltd., Translumina GmbH

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10384&type=smp

What Is Covered In The Pediatric Interventional Cardiology Global Market Report?

• Market Size Forecast: Examine the pediatric interventional cardiology market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the pediatric interventional cardiology market for a structured understanding.
• Key Players Overview: Analyze major players in the pediatric interventional cardiology market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the pediatric interventional cardiology market.
• Segment Contributions: Evaluate how different segments drive overall growth in the pediatric interventional cardiology market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the pediatric interventional cardiology market.
• Industry Challenges: Identify potential risks and obstacles affecting the pediatric interventional cardiology market.
• Competitive Landscape: Review strategic developments in the pediatric interventional cardiology market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.